Search Results - "Wingren, S."

CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study Populations by Province, M A, Goetz, M P, Brauch, H, Flockhart, D A, Hebert, J M, Whaley, R, Suman, V J, Schroth, W, Winter, S, Zembutsu, H, Mushiroda, T, Newman, W G, Lee, M-T M, Ambrosone, C B, Beckmann, M W, Choi, J-Y, Dieudonné, A-S, Fasching, P A, Ferraldeschi, R, Gong, L, Haschke-Becher, E, Howell, A, Jordan, L B, Hamann, U, Kiyotani, K, Krippl, P, Lambrechts, D, Latif, A, Langsenlehner, U, Lorizio, W, Neven, P, Nguyen, A T, Park, B-W, Purdie, C A, Quinlan, P, Renner, W, Schmidt, M, Schwab, M, Shin, J-G, Stingl, J C, Wegman, P, Wingren, S, Wu, A H B, Ziv, E, Zirpoli, G, Thompson, A M, Jordan, V C, Nakamura, Y, Altman, R B, Ames, M M, Weinshilboum, R M, Eichelbaum, M, Ingle, J N, Klein, T E

“…The International Tamoxifen Pharmacogenomics Consortium was established to address the controversy regarding cytochrome P450 2D6 (CYP2D6) status and clinical…”
Get full text

Catechol-O-Methyltransferase ( ) gene polymorphism and breast cancer risk in young women by BERGMAN-JUNGESTRÖM, M, WINGREN, S

“…Oestrogen exposure has long been considered to be a main risk factor of breast cancer. More recently, interest has also focused on the possible carcinogenic…”
Get full text

Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma by Sun, X F, Carstensen, J M, Zhang, H, Stål, O, Wingren, S, Hatschek, T, Nordenskjöld, B

“…Mutation of p53, a tumour-suppressor protein, leads to overexpression of the protein and loss of its tumour-suppressive properties. In some tumours (eg,…”
Get more information

Rapid typing of neonatal Staphylococcus epidermidis isolates using polymerase chain reaction for repeat regions in surface protein genes by Ohlin, A, Bäckman, A, Söderquist, B, Wingren, S, Björkqvist, M

“…Staphylococcus epidermidis is a significant pathogen in neonatal sepsis and other nosocomial infections. For further investigations of the colonisation…”
Get full text

Incidence and prognosis in early onset breast cancer by Sundquist, M., Thorstenson, S., Brudin, L., Wingren, S., Nordenskjöld, B.

“…The aim of this study was to assess the incidence and prognosis in early onset breast cancer. Age-adjusted incidence and death rate for the 5394 Swedish women…”
Get full text

c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer by Stål, O., Sullivan, S., Wingren, S., Skoog, L., Rutqvist, L.E., Carstensen, J.M., Nordenskjöld, B.

“…Frozen tissue from primary tumours of 152 premenopausal breast cancer patients, who participated in a trial comparing radiotherapy with adjuvant chemotherapy…”
Get full text

p53 and survival in early onset breast cancer : Analysis of gene mutations, loss of heterozygosity and protein accumulation by GENTILE, M, JUNGESTRÖM, M. B, OLSEN, K. E, SÖDERKVIST, P, WINGREN, S

“…The p53 protein has proven to be central in tumorigenesis by its cell cycle regulatory properties and both gene mutations and protein accumulation have been…”
Get full text

Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival by GENTILE, M, OLSEN, K, DUFMATS, M, WINGREN, S

“…Previous studies have demonstrated that the pathological features of breast cancer are more aggressive in younger women than in their older counterparts, and…”
Get full text

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer by STÅL, O, SKOOG, L, RUTQVIST, L. E, CARSTENSEN, J. M, WINGREN, S, SULLIVAN, S, ANDERSSON, C, DUFMATS, M, NORDENSKJÖLD, B

“…Cancer chemotherapy interacts with cell proliferation, but data on the relationship between cancer cell replication and the effect of adjuvant chemotherapy are…”
Get full text

Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin by WINGREN, S, STÅL, O, NORDENSKJÖLD, B

Get full text

Flow cytometric gating on cytokeratin-containing DNA aneuploid breast cancer cells improves the prediction of recurrence by Wingren, S., Stål, O.

Get full text

Human malignant fibrous histiocytomas in vitro: growth characteristics and their association with expression of mRNA for platelet-derived growth factor, transforming growth factor-alpha and their receptors by Abdiu, A, Walz, T.M, Nishikawa, B.K, Wingren, S, Larsson, S.E, Wasteson, Å

“…Eight human malignant fibrous histiocytomas were examined in vitro, in order to relate their growth properties to mRNA expression for platelet-derived growth…”
Get full text

S-phase fraction is a prognostic factor in stage I breast carcinoma by Stål, O, Dufmats, M, Hatschek, T, Carstensen, J, Klintenberg, C, Rutqvist, L E, Skoog, L, Sullivan, S, Wingren, S, Nordenskjöld, B

“…The prognostic significance of cell proliferation, estimated as cytometric S-phase fraction (SPF), was investigated in node-negative breast cancer patients…”
Get more information

Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma by Karlsson, M., Boeryd, B., Carstensen, J., Frånlund, B., Gustafsson, B., Kågedal, B., Sun, X.-F., Wingren, S.

“…In 79 patients with uveal melanoma, the tumours were investigated by DNA flow cytometry and immunohistochemical staining of PCNA and Ki-67. S-phase as a…”
Get full text

Frequent allelic losses on chromosome 13q in human male breast carcinomas by Wingren, S, van den Heuvel, A, Gentile, M, Olsen, K, Hatschek, T, Söderkvist, P

“…Loss of genetic material on chromosomes 13q and 17 has been suggested to be of importance in the initiation and progression of female breast cancer, but their…”
Get full text

125P Components of the PI3K/Akt pathway as prognostic factors in metastatic HER2-positive breast cancer treated with trastuzumab by Veenstra, C., Ellegard, S., Perez-Tenorio, G., FagerstrOm, V., Garsjo, J., Briedis, K., Sundqvist, M., MalmstrOm, A., Wingren, S., Stai, O.

Get full text

125P Components of the PI3K/Akt pathway as prognostic factors in metastatic HER2-positive breast cancer treated with trastuzumab by Veenstra, C., Ellegård, S., Pérez-Tenorio, G., Fagerström, V., Gårsjö, J., Briedis, K., Sundqvist, M., Malmström, A., Wingren, S., Stål, O.

Get full text

DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas by KARLSSON, M, BOERYD, B, CARSTENSEN, J, KAGEDAL, B, WINGREN, S

“…In 96 patients with uveal malignant melanomas the tumours were investigated by DNA flow cytometry. Thirty-eight per cent of the melanomas were aneuploid. By…”
Get full text

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients by Wegman, Pia, Vainikka, Linda, Stål, Olle, Nordenskjöld, Bo, Skoog, Lambert, Rutqvist, Lars-Erik, Wingren, Sten

“…Tamoxifen is widely used as endocrine therapy for oestrogen-receptor-positive breast cancer. However, many of these patients experience recurrence despite…”
Get full text

Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. South East Sweden Breast Cancer Group by Wingren, S, Stål, O, Nordenskjöld, B

“…We investigated distant recurrence and S-phase fraction (SPF), estimated by flow cytometry with and without selection of the epithelial cell population, in 201…”
Get full text